Additional file 1: of IgG Galactosylation status combined with MYOM2-rs2294066 precisely predicts anti-TNF response in ankylosing spondylitis

Figure S1. A: The variance of BASFI with time course. Figure S2. A: Î IgG-Gal ratio of responders and poor-responders after IgG-Gal ratio screening. Figure S3. MYOM2 gene expression of different alleles (Wilcoxon test). Table S1. Inclusion criteria. Table S2. Mean value of sensitivity, specificity and AUC of different indexes after cross-validation. Table S3. Validation results of the other 5 SNPs that were associated with the response to TNF blocker in the first stage. (DOCX 886 kb)